Profile cover photo
Profile photo
MedChemNet
2 followers -
A network for the medicinal chemistry community to share knowledge
A network for the medicinal chemistry community to share knowledge

2 followers
About
MedChemNet's posts

Post has attachment
In a few hours, we will be joining forces with +Charles River Labs for a live chat on International Women's Day to discuss women in the field of #STEM. Submit your questions to our speakers using the hashtags #MCNTalks #BeBoldForChange #WOMENatCRL

To learn more about the chat, please visit http://bit.ly/2lmW003



Post has attachment
Where can chemistry take you? This is the big question our team looks at this week. Sign up and take a look at our #infographic on where chemistry can take you #careers #recruitment #chemistry 
Photo

Post has attachment
Diabetes management strategies: can nanoparticles be used to therapeutically deliver insulin?

Post has attachment
www.medchemnet.com/users/6223-medchemnet/posts/11719-advances-in-mechanistic-understanding-of-release-rate-control-mechanisms-of-extended-release-hydrophilic-matrix-tablets

This review article, from a team at Bristol-Myers Squibb (Merseyside, UK; Lawrence Township, NJ, USA) discusses approaches to characterizing and developing understanding around the mechanisms that control the release of drugs from extended-release hydrophilic matrix tablets.



Post has attachment
Join the conversation on antimicrobial resistance by attending our Twitter chat!

Join us on Twitter (@MedChemNet) on August 24th at 3pm [BST] for a chance to chat with Professor Kevin Outterson, Dr Matthew Todd and the CARB-X partnership from the field of antimicrobial drug discovery about key topics in the field and recent progress in research.

Pose your questions live or submit a question using the hashtag #MCNTalks to join in the conversation!

• How can we incentivise drug discovery to tackle antimicrobial resistance?
• What can be done to tackle rising antimicrobial resistance in the developing world?
• How can we encourage interdisciplinary collaboration?

Add the event to your calendar! email.medchemnet.com/c/112ZGy8aF38j7YPeLcXHUMt8d 
Photo

Post has attachment
New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition: Free for www.MedChemNet.com members, this Research Article from researchers from the Instituto de Química Médica, the Instituto de Investigaciones Biomédicas “Alberto Sols” (both Madrid, Spain) and the University of Trieste (Italy), explores the potential of neurogenic agents as innovative drugs for the treatment of Alzheimer’s disease.

https://www.medchemnet.com/users/6223-medchemnet/posts/11055-free-article-for-medchemnet-users-new-neurogenic-lipoic-based-hybrids-as-innovative-alzheimer-s-drugs-with-1-agonism-and-secretase-inhibition
Photo

Post has attachment
New algorithm predicts possible drug combinations for drug resistant fungal infections.

Researchers have developed an algorithm that can identify novel drug combinations to tackle drug resistant fungal infections.

www.medchemnet.com/posts/10522-new-algorithm-predicts-possible-drug-combinations-for-drug-resistant-fungal-infections 

Post has attachment
Computational tools, antibiotics and drug discovery: interview with Dr Sriram Chandrasekaran: https://www.medchemnet.com/users/5610-stella-bennett/videos/10325-chandrasekaran

Post has attachment
Check out our list of new drug approvals in May 2016: https://www.medchemnet.com/posts/6848-new-drug-approvals-may-2016 
Photo

Post has attachment
MedChemNet is on Facebook! We're pretty excited to share all the latest drug discovery and medicinal chemistry news with our newest network :D
Wait while more posts are being loaded